Global stem cell market cagr to be 26 percent from 2017-2025.
LONDON, U.K., April 4, 2017--The global market for stem cells is anticipated to expand at a CAGR of 26 percent from 2017-2025, according to a report by Inkwood Research.
The rise in neurodegenerative diseases is the primary factor for the growth of the stem cell market.
The market is segmented on the basis of product, technology, application, and geography.
The market is further segmented into adult stem cell, embryonic stem cell, induced pluripotent market and rat neutral market.
Technology is segmented into stem cell acquisition, stem cell production, stem cell cryo-preservation and stem cells expansion and subculture. Applications include stem cells regenerative medicine and drug discovery and development.
Market geography comprises North America, Europe, Asia-Pacific and rest of the world.
The upsurge in neurodegenerative ailments, growing investments in R&D, government subsidy and sustenance, advancements in the applications of stem cells, significant growth in medical tourism, and stem cell banking are driving the market.
The market in North America is expected to have the largest share by 2025. Increased investments in research and development activities and popular pharmaceuticals have contributed to the growth of the U.S. market.
Asia-Pacific is anticipated to grow at CAGR of 26 percent, the fastest growing region among others. Growth is primarily driven by growing chronic lifestyle diseases and government support and initiatives.
Europe generated revenue of $13.5 billion in 2016. The Europe stem cell analysis market is primarily driven by the rising prevalence of chronic disorders such as cancer and cardiovascular disorders.
The players in the market include Cytori Therapeutics Inc., Fibrocell Science, Cellartis AB, Biotime Inc., GE Healthcare, Thermo Fisher Scientific Pvt Ltd., Stem Cell Technologies, Cellular Dynamics International (holding company Fujifilm), Vericel Corporation, Brainstorm Cell Therapeutics, California Stem Cell Inc., Beckton Dickinson, Stryker Corporation, Celgene Corporation. Some major companies involved in stem cells include: GE Healthcare, Stem Cell Technology, Thermo Fisher, Becton, Corning, and others.
Global Stem Cell Market Forecast 2017-2025, March 2017, Inkwood Research,
192 pages, $3,911
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Market Research|
|Publication:||Stem Cell Lab World|
|Date:||Apr 17, 2017|
|Previous Article:||Cell isolation/cell separation market size: $16B by 2025.|
|Next Article:||Companies establish joint stem cell technology lab in China.|